Condition: Human Papilloma Virus · Vaginal Flora Imbalance · Cancer Cervix Uterus · Sponsor: Hadassah Medical Organization
In this study, the investigators will prospectively collect, analyze and integrate information regarding vaginal microbiome composition and HPV presence in women with cervical pathologies (high-grade CIN and CC) and controls, to construct a large dataset from patients with pre-cancerous cervical lesions and healthy women, to evaluate the personalized contribution of the vaginal microbiome to the CIN-CC sequence.
This description comes directly from the study's public registry record.
Ahinoam Lev Sagie, MD · +972-54-4327178 · levsagie@netvision.net.il
Lilah Tsaitlin Mor, MD · +972-54-7753434 · lilah.tsaitlin@gmail.com
Always discuss trial participation with your own doctor first.
| Hadassah Medical Center | Jerusalem, Israel | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05640700